First Citizens Bank & Trust CO Haemonetics Corp Transaction History

First Citizens Bank & Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 14, 2021	SELL	$51.81 - $118.56 $139,576 - $319,400	-2,694 Closed	0 $0
Q1 2021 Apr 14, 2021	BUY	$111.01 - $139.48 $85,144 - $106,981	767 Added 39.8%	2,694 $299,000
Q4 2020 Jan 13, 2021	BUY	$88.75 - $119.95 $19,170 - $25,909	216 Added 12.62%	1,927 $229,000
Q3 2019 Oct 18, 2019	SELL	$117.16 - $138.52 $170,936 - $202,100	-1,459 Reduced 46.03%	1,711 $216,000
Q2 2019 Jul 11, 2019	BUY	$81.74 - $120.34 $817 - $1,203	10 Added 0.32%	3,170 $381,000
Q1 2019 Apr 12, 2019	BUY	$83.25 - $102.12 $72,011 - $88,333	865 Added 37.69%	3,160 $276,000
Q4 2018 Jan 15, 2019	BUY	$90.66 - $116.63 $208,064 - $267,665	2,295 New	2,295 $230,000

334

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.58B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on First Citizens Bank & Trust CO with notifications on news.